Similar articles

• The role of tissue factor pathway inhibitor in tumor growth and metastasis.

  Amirkhosravi A, Meyer T, Amaya M, Davila M, Mousa SA, Robson T, Francis JL. Amirkhosravi A, et al. Semin Thromb Hemost. 2007 Oct;33(7):643-52. doi: 10.1055/s-2007-991531. Semin Thromb Hemost. 2007. PMID: 18000790 Review.
• Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli--a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli.

  Randolph MM, White GL, Kosanke SD, Bild G, Carr C, Galluppi G, Hinshaw LB, Taylor FB Jr. Randolph MM, et al. Thromb Haemost. 1998 May;79(5):1048-53. Thromb Haemost. 1998. PMID: 9609245
• Evaluating the role of serine protease inhibition in the management of tumor micrometastases.

  Putnam JB, Royston D, Chambers AF, Dunbar S, Lemmer JH, Norman P, Travis E, Vaporciyan AA, Yang S, Zacharski LR. Putnam JB, et al. Oncology (Williston Park). 2003 Oct;17(10 Suppl 10):9-30; quiz 31-2. Oncology (Williston Park). 2003. PMID: 14606367 Review. No abstract available.
• Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma.

  Amirkhosravi A, Meyer T, Chang JY, Amaya M, Siddiqui F, Desai H, Francis JL. Amirkhosravi A, et al. Thromb Haemost. 2002 Jun;87(6):930-6. Thromb Haemost. 2002. PMID: 12083498
• [Tissue factor pathway inhibitors].

  Sierko E, Zawadzki RJ, Wojtukiewicz MZ. Sierko E, et al. Pol Merkur Lekarski. 2002 Jul;13(73):66-9. Pol Merkur Lekarski. 2002. PMID: 12362512 Review. Polish.